Health
New drug candidate to fight COVID-19 – Goondiwindi Argus
A drug described as potential new immunotherapy for COVID-19 will enter a clinical trial in the USA led by former Australian of the Year Professor Ian Frazer.
A drug described as potential new immunotherapy for COVID-19 will enter a clinical trial in the USA led by former Australian of the Year Professor Ian Frazer.
Developed by Brisbane and Seattle-based company, Implicit Bioscience, the drug IC14 will this week be tested in COVID-19 patients in 10-15 hospitals across the United States.
The new drug, for which Prof Frazer is the clinical immunologist and chief scientific officer, will treat immune responses to COVID-19 and its health complications.
Its…
-
Noosa News16 hours agoBrisbane vs Collingwood live blog: Richmond selects Noah Balta as unbeaten Lions prepare for Magpies test
-
General15 hours agoNT Coalition candidate Lisa Siebert diverges from Jacinta Nampijinpa Price on royal commission call
-
General23 hours agoMinecraft mayhem: ‘Chicken jockey’ chaos reaches Australian cinemas
-
General17 hours agoCanberra man named as doctor accused of rape after suppression order lifted